FDA Holds Off Approval of New Merck Drug
As expected, the FDA is holding off on Merck’s new COX-2, Arcoxia. I’ve been bombarded with ads saying it’s “coming soon”. I guess not.
FDA Holds Off Approval of New Merck Drug
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Shy doctors can lead: imposter syndrome and the path to physician leadership
Bringing a newborn home? What hospitals don’t tell new parents
Physician pay won’t budge for one doctor. Negotiate as a group.
Is your clinical AI tool safe? 4 questions to ask first
Fired for seeing her own patients: moral injury and life after medicine
U.S. health care won’t be fixed until everyone can see a doctor
